Montgomery Ruling — MFDS Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — The risk must be discussed because this particular patient would likely attach significance to it; reasonable alternative or variant treatments must also be discussed.
Explanation lettering: C = shown as A · D = shown as C · E = shown as D · A = shown as E
A is correct. Montgomery replaced the clinician-centred Bolam approach to disclosure with a patient-centred test of materiality. A risk is material if a reasonable person in the patient's position would likely attach significance to it, or if the clinician is or should reasonably be aware that the particular patient would do so. The patient's occupation makes persistent altered sensation potentially material despite a low probability. Reasonable alternative or variant treatments must also be discussed. B incorrectly applies Bolam to risk disclosure. C is wrong because materiality has no fixed numerical threshold and depends on both likelihood and consequences. D mistakes a signed form for the individualised consent dialogue. E wrongly excludes reasonable alternatives from the disclosure duty.
Reference: Royal College of Surgeons of England, Consent: Supported Decision-Making — A Guide to Good Practice, sections 1 and 4.3, November 2018. https://www.rcseng.ac.uk/-/media/files/rcs/standards-and-research/standards-and-policy/good-practice-guides/new-docs-may-2019/rcs-_consent-supported-decision-making.pdf